Top Markets
Coin of the day
Tricida, Inc. Tricida, Inc.

Tricida, Inc.

TCDA
Rank in Stocks #35026
Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the... Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the advancement and market introduction of veverimer (TRC101). This compound, an orally ingested, non-systemic polymer, has successfully concluded its Phase III clinical trials. Veverimer is designed to address metabolic acidosis in individuals suffering from chronic kidney disease by specifically targeting and eliminating excess acid within the gastrointestinal tract. The company was established in 2013 and is headquartered in South San Francisco, California.
Share Price
$0.108
Last synced: 2023-01-23
Market Cap
$4.56M
Change (1 day)
-10.00%
Change (1 year)
0.00%
Country
US
Trade Tricida, Inc. (TCDA)

Category

Price of TCDA with the market cap of B
Tricida, Inc. Tricida, Inc.
TCDA
$0.108
Market Capitalization of Tricida, Inc.(TCDA)
Market Cap: $4.56M
As of August 2026 Tricida, Inc. has a market cap of $4.56M. This makes Tricida, Inc. the world's 35026th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Tricida, Inc. from 2018 to 2026
TCDA compared with Top 5 Most Popular stocks
Price of TCDA Asset B Mkt. of B Results
Tricida, Inc. Tricida, Inc.
$128,978 $4.56M
$5.452T +119,424,252.46%
Tricida, Inc. Tricida, Inc.
$106,223 $4.56M
$4.490T +98,354,771.67%
Tricida, Inc. Tricida, Inc.
$98,472.71 $4.56M
$4.162T +91,178,334.11%
Tricida, Inc. Tricida, Inc.
$86,973.57 $4.56M
$3.676T +80,530,983.42%
Tricida, Inc. Tricida, Inc.
$67,023.09 $4.56M
$2.833T +62,058,316.97%